Loading...
Loading...
Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc.. Spoken Alpha tracks CBIH's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks CBIH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CBIH.
curl https://api.spokenalpha.com/v1/companies/CBIH| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.90 | $4.18 | +17.2% | -1.1% | -1.2% |
| Q4 FY2026 | $5.31 | $4.44 | +19.6% | -1.9% | -2.1% |
| Q3 FY2026 | $4.85 | $4.33 | +12.0% | -2.8% | -0.9% |
| Q2 FY2026 | $4.71 | $4.28 | +10.1% | -2.6% | -0.4% |
| Q1 FY2025 | $4.77 | $4.46 | +7.0% | -8.9% | -8.3% |
| Q4 FY2025 | $5.11 | $4.53 | +12.9% | -3.9% | -2.0% |
| Q3 FY2025 | $5.17 | $4.51 | +14.7% | -2.0% | -3.4% |
| Q2 FY2025 | $5.14 | $4.45 | +15.6% | +1.4% | -1.5% |
| Q1 FY2024 | $5.39 | $4.43 | +21.6% | -6.6% | -3.8% |
| Q4 FY2024 | $4.91 | $4.39 | +11.9% | +2.4% | +1.8% |